Coping with menopausal symptoms: An internet survey of Belgian postmenopausal women.
OBJECTIVE
An internet survey was performed to obtain data on the current use in Belgium of hormone replacement therapy and alternative treatments for the alleviation of menopausal symptoms. A supplementary aim was to assess the use of opt-in internet opinion panels (TalkToChange, http://www.talktochange.com, and GMI, http://www.gmi-mr.com/global-panel) as a potential new way to obtain data on menopausal issues.


METHODS
Data were collected via an internet platform from 696 postmenopausal women aged 45-60 years.


METHODS
Respondents were asked questions about their socio-demographic profile, their experience of the menopause, the burden of the menopause, its impact on their quality of life and the treatment of menopausal symptoms (if any).


RESULTS
The opt-in internet opinion panels proved a quick way (19days) to obtain reliable information with a low error margin (3.7%). The online survey collected detailed socio-demographic data. Almost all of the women (98%) had heard about the menopause before. Sixty-one percent perceived the menopause as a temporary phase (17% thought it lasted for one or two years and 44% thought it lasted for three to five years) and only 39% realized the menopause would last for the rest of their life. Twenty-three percent of the women reported any kind of impact of the menopause on their quality of life. However, for the other 77% the menopause had resulted in complaints. No differences according to the women's age, level of education or professional status were found in this respect. Sixty-nine percent of the women had 'ever' used some type of treatment for menopausal symptoms and 53% were currently using a treatment. Forty percent of those with more than three symptoms were currently untreated. Of those who were not on hormone replacement therapy (HRT), 61% would not consider taking it (54% were 'strongly opposed' and 7% simply 'opposed'), while 8% would consider asking their doctor for HRT. Among those women who were opposed to HRT, 25% indicated that they were afraid of the increased risk of breast cancer, 34% cited cardiovascular risks and 26% were worried about weight gain. In this Belgian sample, HRT was used significantly more often by French-speaking women (32%) than by Dutch-speaking women (9%) (OR 4.4, p<0.0001). The alternatives to HRT had a high satisfaction rate among users. Relaxation techniques, regular physical activity, acupuncture and avoiding stress had satisfaction rates similar to that with HRT. It was not possible to compare the alternatives in the same women. Nor was it possible to assess whether more pronounced symptoms required a specific treatment.


CONCLUSIONS
Opt-in internet opinion panels proved a quick and efficient way to gather data on menopausal issues in Belgium. Despite the high levels of awareness and knowledge, there is some confusion concerning the duration of the menopause, and its common perception as a temporary condition is likely to mean that the menopausal burden is substantially underestimated. Many symptomatic women are untreated.
Breast and Menopause, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium. Electronic address: Herman.depypere@ugent.be.
H
H
Depypere
Reproductive Endocrinology, Centre Hospitalier Universitaire Liege, Sart Tilman, 4020, Liège, Belgium.
A
A
Pintiaux
Service universitaire de sénologie, Centre Hospitalier Régional de la Citadelle, Boulevard du 12ème de Ligne 1, 4000 Liège, Belgium. Electronic address: joelle.desreux@chu.ulg.ac.be.
J
J
Desreux
Nieuwstraat 67 9340 Lede, Belgium. Electronic address: mieke.hendrickx@belgacom.net.
M
M
Hendrickx
University Hospital, Herestraat 49, 3000 Leuven, Belgium.
P
P
Neven
CHIREC Edith Cavell 32, Rue Edith Cavell 1180 Bruxelles, Belgium.
E
E
Marchowicz
Universite Erasme, Route de Lennik 808 1070 Brussels, Belgium.
V
V
Albert
Varenslaan 6, 1950 Kraainem, Belgium.
V
V
Leclercq
Life Sciences & Healthcare, InSites Consulting, Belgium.
S
S
Van den Branden
CHU Saint-Pierre, UMC Sint-Pieter, Rue Haute -322, 1000 Brussels, Belgium, Belgium.
S
S
Rozenberg
D000223:Adaptation, Psychological; D001530:Belgium / Q000453:epidemiology; D001943:Breast Neoplasms; D002318:Cardiovascular Diseases; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D020407:Internet; D008593:Menopause / Q000523:psychology; D008875:Middle Aged; D011788:Quality of Life; D012306:Risk; D011795:Surveys and Questionnaires; D015430:Weight Gain